BlackRock’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.63B Sell
12,954,765
-1,727,629
-12% -$217M 0.03% 452
2025
Q1
$1.62B Sell
14,682,394
-100,328
-0.7% -$11.1M 0.03% 444
2024
Q4
$2.02B Buy
14,782,722
+526,674
+4% +$71.9M 0.04% 383
2024
Q3
$1.64B Buy
14,256,048
+65,340
+0.5% +$7.53M 0.03% 444
2024
Q2
$1.95B Buy
14,190,708
+429,738
+3% +$59.2M 0.04% 367
2024
Q1
$1.9B Buy
13,760,970
+113,079
+0.8% +$15.6M 0.04% 378
2023
Q4
$1.8B Buy
13,647,891
+276,493
+2% +$36.4M 0.05% 368
2023
Q3
$1.5B Sell
13,371,398
-110,744
-0.8% -$12.5M 0.04% 396
2023
Q2
$1.27B Buy
13,482,142
+15,492
+0.1% +$1.46M 0.04% 461
2023
Q1
$1.36B Buy
13,466,650
+838,997
+7% +$84.9M 0.04% 416
2022
Q4
$1.51B Buy
12,627,653
+580,508
+5% +$69.3M 0.05% 379
2022
Q3
$1.28B Buy
12,047,145
+127,555
+1% +$13.5M 0.04% 408
2022
Q2
$1.16B Buy
11,919,590
+324,173
+3% +$31.6M 0.04% 458
2022
Q1
$1.09B Buy
11,595,417
+118,872
+1% +$11.1M 0.03% 549
2021
Q4
$977M Buy
11,476,545
+1,258,312
+12% +$107M 0.02% 614
2021
Q3
$980M Buy
10,218,233
+79,736
+0.8% +$7.65M 0.03% 592
2021
Q2
$987M Sell
10,138,497
-850,977
-8% -$82.8M 0.03% 602
2021
Q1
$1.07B Buy
10,989,474
+3,991,679
+57% +$388M 0.03% 551
2020
Q4
$671M Buy
6,997,795
+182,933
+3% +$17.5M 0.02% 702
2020
Q3
$655M Sell
6,814,862
-691,828
-9% -$66.5M 0.02% 608
2020
Q2
$916M Buy
7,506,690
+551,286
+8% +$67.3M 0.04% 458
2020
Q1
$602M Buy
6,955,404
+363,852
+6% +$31.5M 0.03% 534
2019
Q4
$709M Buy
6,591,552
+655,434
+11% +$70.5M 0.03% 610
2019
Q3
$535M Buy
5,936,118
+277,587
+5% +$25M 0.02% 699
2019
Q2
$478M Buy
5,658,531
+163,195
+3% +$13.8M 0.02% 768
2019
Q1
$484M Buy
5,495,336
+516,419
+10% +$45.5M 0.02% 754
2018
Q4
$356M Sell
4,978,917
-120,359
-2% -$8.59M 0.02% 867
2018
Q3
$627M Buy
5,099,276
+16,724
+0.3% +$2.06M 0.03% 627
2018
Q2
$499M Buy
5,082,552
+174,057
+4% +$17.1M 0.02% 730
2018
Q1
$407M Buy
4,908,495
+132,749
+3% +$11M 0.02% 827
2017
Q4
$371M Sell
4,775,746
-81,372
-2% -$6.31M 0.02% 904
2017
Q3
$298M Buy
4,857,118
+54,891
+1% +$3.36M 0.02% 1030
2017
Q2
$221M Sell
4,802,227
-229,706
-5% -$10.6M 0.01% 1208
2017
Q1
$218M Buy
5,031,933
+4,996,784
+14,216% +$216M 0.01% 1206
2016
Q4
$1.36M Sell
35,149
-41,659
-54% -$1.61M ﹤0.01% 1355
2016
Q3
$3.89M Buy
76,808
+4,569
+6% +$231K 0.01% 961
2016
Q2
$3.28M Buy
72,239
+8,247
+13% +$375K ﹤0.01% 968
2016
Q1
$2.53M Sell
63,992
-9,408
-13% -$372K ﹤0.01% 1018
2015
Q4
$4.15M Buy
73,400
+26,591
+57% +$1.5M 0.01% 879
2015
Q3
$1.86M Sell
46,809
-7,337
-14% -$292K ﹤0.01% 1063
2015
Q2
$2.59M Sell
54,146
-1,581
-3% -$75.5K ﹤0.01% 1014
2015
Q1
$2.21M Sell
55,727
-18,237
-25% -$724K ﹤0.01% 1043
2014
Q4
$1.65M Sell
73,964
-38,200
-34% -$853K ﹤0.01% 1094
2014
Q3
$1.76M Sell
112,164
-8,900
-7% -$139K ﹤0.01% 1065
2014
Q2
$1.8M Buy
121,064
+3,865
+3% +$57.4K ﹤0.01% 1044
2014
Q1
$1.89M Buy
117,199
+115,012
+5,259% +$1.85M ﹤0.01% 1061
2013
Q4
$21K Hold
2,187
﹤0.01% 2305
2013
Q3
$25K Hold
2,187
﹤0.01% 2137
2013
Q2
$29K Buy
+2,187
New +$29K ﹤0.01% 2086